{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:19:30Z","timestamp":1793020770354,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.lana.2026.101457","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:10:44Z","timestamp":1774433444000},"page":"101457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Remote digital intervention targeting heart failure medical therapy: a randomized controlled trial"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4679-2221","authenticated-orcid":false,"given":"Adam D.","family":"DeVore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0186-5191","authenticated-orcid":false,"given":"Cynthia L.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy M.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir R.","family":"Haghighat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunit-Preet","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirak","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mosi K.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Stanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5247-0897","authenticated-orcid":false,"given":"Ashul","family":"Govil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trejeeve","family":"Martyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4294-0570","authenticated-orcid":false,"given":"Jaime","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7007-9437","authenticated-orcid":false,"given":"Mirza S.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lana.2026.101457_bib1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamacardio.2024.0615","article-title":"Reversals in the decline of heart failure mortality in the US, 1999 to 2021","volume":"9","author":"Sayed","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.lana.2026.101457_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cardfail.2024.07.001","article-title":"HF STATS 2024: heart failure epidemiology and outcomes statistics an updated 2024 report from the Heart Failure Society of America","volume":"31","author":"Bozkurt","year":"2025","journal-title":"J Card Fail"},{"issue":"19","key":"10.1016\/j.lana.2026.101457_bib3","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jacc.2019.02.015","article-title":"Titration of medical therapy for heart failure with reduced ejection fraction","volume":"73","author":"Greene","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.lana.2026.101457_bib4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jama.2021.8844","article-title":"Effect of a hospital and postdischarge quality improvement intervention on clinical outcomes and quality of care for patients with heart failure with reduced ejection fraction: the CONNECT-HF randomized clinical trial","volume":"326","author":"DeVore","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.lana.2026.101457_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2022.08.009","article-title":"Heart failure drug treatment\u2014inertia, titration, and discontinuation: a multinational observational study (EVOLUTION HF)","volume":"11","author":"Savarese","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"10367","key":"10.1016\/j.lana.2026.101457_bib6","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.lana.2026.101457_bib7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jchf.2024.10.014","article-title":"Digital solutions for the optimization of pharmacologic therapy for heart failure","volume":"13","author":"DeVore","year":"2025","journal-title":"JACC Heart Fail"},{"issue":"18","key":"10.1016\/j.lana.2026.101457_bib8","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.lana.2026.101457_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ahj.2025.06.001","article-title":"Rationale, design, and baseline characteristics of the virtual care to improve heart failure outcomes (VITAL-HF) trial","volume":"290","author":"Khan","year":"2025","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.lana.2026.101457_bib10","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jacc.2021.11.033","article-title":"Optimal background pharmacological therapy for heart failure patients in clinical trials: JACC review topic of the week","volume":"79","author":"Fiuzat","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.lana.2026.101457_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011164","article-title":"Generalizable approach to quantifying guideline-directed medical therapy","volume":"17","author":"Khan","year":"2024","journal-title":"Circ Heart Fail"},{"issue":"8","key":"10.1016\/j.lana.2026.101457_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jchf.2022.03.009","article-title":"Effects of dapagliflozin according to the heart failure collaboratory medical therapy score: insights from DAPA-HF","volume":"10","author":"Butt","year":"2022","journal-title":"JACC Heart Fail"},{"issue":"11","key":"10.1016\/j.lana.2026.101457_bib13","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.jchf.2024.05.026","article-title":"Optimal medical therapy and outcomes among patients with chronic heart failure with reduced ejection fraction","volume":"12","author":"Rao","year":"2024","journal-title":"JACC Heart Fail"},{"issue":"3","key":"10.1016\/j.lana.2026.101457_bib14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10741-021-10077-x","article-title":"Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction","volume":"27","author":"Greene","year":"2022","journal-title":"Heart Fail Rev"},{"issue":"8 Pt 1","key":"10.1016\/j.lana.2026.101457_bib15","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jchf.2023.04.015","article-title":"Opportunities and achievement of medication initiation among inpatients with heart failure with reduced ejection fraction","volume":"11","author":"Swat","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"8","key":"10.1016\/j.lana.2026.101457_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.03.045","article-title":"Optimizing medical therapy using remote monitoring and artificial intelligence in patients with heart failure: the TURING-HF trial","volume":"13","author":"Khandwalla","year":"2025","journal-title":"JACC Heart Fail"},{"issue":"4","key":"10.1016\/j.lana.2026.101457_bib17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jchf.2024.02.008","article-title":"The effect of using a remote patient management platform in optimizing guideline-directed medical therapy in heart failure patients","volume":"12","author":"Brahmbhatt","year":"2024","journal-title":"JACC Heart Fail"},{"issue":"10","key":"10.1016\/j.lana.2026.101457_bib18","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1038\/s41591-024-03238-6","article-title":"Digital consults in heart failure care: a randomized controlled trial","volume":"30","author":"Man","year":"2024","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.lana.2026.101457_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/ehjdh\/ztab005","article-title":"Barriers and facilitators of the uptake of digital health technology in cardiovascular care: a systematic scoping review","volume":"2","author":"Whitelaw","year":"2021","journal-title":"Eur Heart J Digit Health"}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X26000876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X26000876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:27:25Z","timestamp":1784118445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X26000876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":19,"alternative-id":["S2667193X26000876"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2026.101457","relation":{},"ISSN":["2667-193X"],"issn-type":[{"value":"2667-193X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Remote digital intervention targeting heart failure medical therapy: a randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2026.101457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101457"}}